期刊
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
卷 9, 期 8, 页码 1296-1301出版社
WILEY
DOI: 10.1002/acn3.51609
关键词
-
资金
- Swedish Federal Government (LUA/ALF) [ALFGBG-722081]
- Swedish Society of the Neurologically Disabled
- Research Foundation of the Multiple Sclerosis Society of Gothenburg
- Edit Jacobson Foundation
- ProjektDEAL
SARS-COV-2 infection can result in MOGAD, but there is no evidence of cross-reactive immune response between the virus and MOG.
SARS-COV-2 frequently cause neurological disorders and is sometimes associated with onset of autoimmune diseases affecting the nervous system. Over recent years, a rare but distinct diagnosis designated myelin oligodendrocyte glycoprotein-associated disorder (MOGAD) has been recognized in patients with attacks of optic neuritis, myelitis, or encephalomyelitis and increased levels of anti-MOG antibodies. The cause of MOGAD is unknown. However, there have been reports of single cases of MOGAD in patients with Covid-19 infection. We report a series of SARS-CoV-2 positive patients that developed MOGAD, but a homology search did not support a cross-reactive immune response to SARS-CoV-2 spike-protein and MOG.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据